{"id":"W2516241120","doi":"10.1016/j.jid.2016.06.069","title":"052 Efficacy of ixekizumab in moderate-to-severe psoriasis patients who have or have not received prior biologic therapies: An integrated analysis of 3 phase 3 studies","year":2016,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Ixekizumab; Placebo; Psoriasis; Medicine; Psoriasis Area and Severity Index; Internal medicine; Plaque psoriasis; Immunology; Secukinumab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004105743,0.0005435924,0.001847385,0.0005966304,0.0002998455,0.001257122,0.0004015379,0.0007387583,0.001247212],"category_scores_gemma":[0.001519647,0.0003468273,0.003032338,0.0005445331,0.0005222564,0.0007439695,0.0002477607,0.001202069,0.0001950564],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005516065,"about_ca_system_score_gemma":0.0007175376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004005777,"about_ca_topic_score_gemma":0.001185346,"domain_scores_codex":[0.9988084,0.0006698819,0.00008231735,0.0001238316,0.0001878174,0.0001278384],"domain_scores_gemma":[0.9986842,0.0005035085,0.0003934064,0.00009847623,0.0001138969,0.000206512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.5807183,0.01329786,0.09599654,0.001556739,0.01567625,0.0002369781,0.0002892299,0.002723851,0.03391912,0.000272357,0.001559673,0.2537532],"study_design_scores_gemma":[0.2635033,0.3628472,0.3422675,0.0002517059,0.01311338,0.0007932739,0.0002707285,0.002361918,0.008186752,0.0004634545,0.005812326,0.000128411],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892936,0.008342095,0.000270913,0.0001379872,0.00004229991,0.0003450846,0.0005338148,0.00002499854,0.001009183],"genre_scores_gemma":[0.9969848,0.001379973,0.000421342,0.0001880229,0.00005970751,0.00008509772,0.0005893268,0.000008059884,0.000283718],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004105743,"threshold_uncertainty_score":0.0217135,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06178205642880785,"score_gpt":0.3235110297294508,"score_spread":0.261728973300643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}